Home  |  Contact

Cellosaurus SJ-GBM2 (CVCL_M141)

[Text version]

Cell line name SJ-GBM2
Synonyms SJ-G2; SJG2
Accession CVCL_M141
Resource Identification Initiative To cite this cell line use: SJ-GBM2 (RRID:CVCL_M141)
Comments Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
Doubling time: 29 hours (PubMed=20922763).
Disease Glioblastoma (NCIt: C3058)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 4Y2M
Category Cancer cell line
STR profile Source(s): COG; PubMed=20922763

Markers:
AmelogeninX
CSF1PO12
D2S133817,24
D3S135815
D5S81812
D7S82012
D8S11798,12
D13S31711,12
D16S53911
D18S5116,17
D19S43312,14
FGA24
TH016,9.3
TPOX8
vWA17,18

Run an STR similarity search on this cell line
Web pages http://www.cogcell.org/dl/BrainTumorDataSheets/SJ-GBM2_Cell_Line_Data_Sheet_COGcell_org.pdf
http://www.cogcell.org/cellreqs-ncipptp.php
http://www.pptpinvitro.org/cell_lines_panel.php
Publications

PubMed=7634381; DOI=10.1007/BF00686188
Houghton P.J., Cheshire P.J., Hallman J.D. II, Lutz L., Friedman H.S., Danks M.K., Houghton J.A.
Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors.
Cancer Chemother. Pharmacol. 36:393-403(1995)

PubMed=9220028; DOI=10.1016/S0303-7207(97)00080-4
Sharif T.R., Luo W., Sharif M.
Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway.
Mol. Cell. Endocrinol. 130:119-130(1997)

PubMed=20922763; DOI=10.1002/pbc.22801
Kang M.H., Smith M.A., Morton C.L., Keshelava N., Houghton P.J., Reynolds C.P.
National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing.
Pediatr. Blood Cancer 56:239-249(2011)

Cross-references
Other Wikidata; Q54953524
Entry history
Entry creation06-May-2013
Last entry updated07-Sep-2018
Version number8